Lamdong Pharmaceutical JSC (HNX:LDP)
8,100.00
-400.00 (-4.71%)
At close: Mar 9, 2026
HNX:LDP Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 18,614 | 11,451 | 16,205 | 16,619 | 65,159 | Upgrade
|
| Short-Term Investments | 2,215 | 3,014 | 2,896 | 1,788 | - | Upgrade
|
| Trading Asset Securities | - | 2,692 | 1,121 | - | - | Upgrade
|
| Cash & Short-Term Investments | 20,829 | 17,157 | 20,222 | 18,407 | 65,159 | Upgrade
|
| Cash Growth | 21.40% | -15.15% | 9.86% | -71.75% | 130.59% | Upgrade
|
| Accounts Receivable | 59,599 | 27,466 | 21,535 | 21,415 | 23,286 | Upgrade
|
| Other Receivables | 1,662 | 1,207 | 1,238 | 10,819 | 432.72 | Upgrade
|
| Receivables | 62,893 | 36,673 | 30,773 | 32,234 | 23,719 | Upgrade
|
| Inventory | 55,422 | 48,962 | 37,751 | 55,919 | 54,575 | Upgrade
|
| Prepaid Expenses | 1,864 | 2,076 | 220.82 | 957.04 | 284.73 | Upgrade
|
| Other Current Assets | 118,935 | 51,865 | 51,026 | 51,458 | 545.85 | Upgrade
|
| Total Current Assets | 259,943 | 156,733 | 139,993 | 158,976 | 144,283 | Upgrade
|
| Property, Plant & Equipment | 38,655 | 42,555 | 46,329 | 55,742 | 60,718 | Upgrade
|
| Other Intangible Assets | - | 68.6 | 229.47 | 491.92 | 740.21 | Upgrade
|
| Other Long-Term Assets | 9,306 | 7,800 | 8,221 | 13,164 | 10,180 | Upgrade
|
| Total Assets | 307,903 | 207,157 | 194,773 | 228,374 | 215,921 | Upgrade
|
| Accounts Payable | 30,970 | 31,545 | 23,549 | 31,801 | 13,964 | Upgrade
|
| Accrued Expenses | 23,409 | 16,705 | 8,887 | 7,216 | 3,345 | Upgrade
|
| Short-Term Debt | 56,974 | 55,026 | 65,368 | 70,298 | 29,960 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 591.64 | - | - | Upgrade
|
| Current Income Taxes Payable | - | 172.69 | 157.19 | 1,063 | 7,209 | Upgrade
|
| Current Unearned Revenue | 134.18 | 134.18 | - | 60 | 72 | Upgrade
|
| Other Current Liabilities | 4,298 | 2,520 | 2,134 | 3,138 | 3,933 | Upgrade
|
| Total Current Liabilities | 115,785 | 106,103 | 100,687 | 113,574 | 58,483 | Upgrade
|
| Long-Term Debt | - | - | - | 591.64 | 2,339 | Upgrade
|
| Other Long-Term Liabilities | 1,780 | 1,770 | 1,720 | 1,720 | 1,720 | Upgrade
|
| Total Liabilities | 117,565 | 107,873 | 102,407 | 115,886 | 62,541 | Upgrade
|
| Common Stock | 187,282 | 127,032 | 127,032 | 127,032 | 127,032 | Upgrade
|
| Retained Earnings | 3,057 | -27,747 | -34,666 | -14,543 | 26,348 | Upgrade
|
| Treasury Stock | -0.32 | -0.32 | -0.32 | -0.32 | -0.32 | Upgrade
|
| Shareholders' Equity | 190,338 | 99,284 | 92,366 | 112,489 | 153,380 | Upgrade
|
| Total Liabilities & Equity | 307,903 | 207,157 | 194,773 | 228,374 | 215,921 | Upgrade
|
| Total Debt | 56,974 | 55,026 | 65,960 | 70,889 | 32,299 | Upgrade
|
| Net Cash (Debt) | -36,145 | -37,869 | -45,738 | -52,482 | 32,860 | Upgrade
|
| Net Cash Per Share | -1929.89 | -2981.05 | -3600.54 | -4132.07 | 2586.61 | Upgrade
|
| Filing Date Shares Outstanding | 18.73 | 12.7 | 12.7 | 12.7 | 12.7 | Upgrade
|
| Total Common Shares Outstanding | 18.73 | 12.7 | 12.7 | 12.7 | 12.7 | Upgrade
|
| Working Capital | 144,158 | 50,630 | 39,305 | 45,402 | 85,800 | Upgrade
|
| Book Value Per Share | 10163.23 | 7815.75 | 7271.08 | 8855.18 | 12073.06 | Upgrade
|
| Tangible Book Value | 190,338 | 99,216 | 92,136 | 111,997 | 152,640 | Upgrade
|
| Tangible Book Value Per Share | 10163.23 | 7810.35 | 7253.02 | 8816.45 | 12014.79 | Upgrade
|
| Buildings | 62,465 | 62,604 | 62,903 | - | - | Upgrade
|
| Machinery | 37,950 | 61,717 | 62,170 | - | - | Upgrade
|
| Construction In Progress | 2,995 | 2,851 | - | 690.2 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.